Akero Therapeutics Inc (AKRO)
31.20
+0.56
(+1.84%)
USD |
NASDAQ |
Nov 21, 16:00
31.22
+0.02
(+0.06%)
Pre-Market: 20:00
Akero Therapeutics Total Liabilities (Quarterly): 79.22M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 79.22M |
| June 30, 2024 | 66.98M |
| March 31, 2024 | 65.99M |
| December 31, 2023 | 44.96M |
| September 30, 2023 | 52.20M |
| June 30, 2023 | 47.37M |
| March 31, 2023 | 42.47M |
| December 31, 2022 | 30.01M |
| September 30, 2022 | 35.90M |
| June 30, 2022 | 37.30M |
| March 31, 2022 | 23.35M |
| December 31, 2021 | 26.44M |
| Date | Value |
|---|---|
| September 30, 2021 | 24.90M |
| June 30, 2021 | 17.88M |
| March 31, 2021 | 11.60M |
| December 31, 2020 | 14.63M |
| September 30, 2020 | 13.58M |
| June 30, 2020 | 10.40M |
| March 31, 2020 | 8.298M |
| December 31, 2019 | 9.392M |
| September 30, 2019 | 6.759M |
| June 30, 2019 | 4.779M |
| March 31, 2019 | 2.404M |
| December 31, 2018 | 127.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.298M
Minimum
Mar 2020
79.22M
Maximum
Sep 2024
33.14M
Average
28.22M
Median
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 296.11M |
| 89bio Inc | 80.20M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 817.55M |
| Shareholders Equity (Quarterly) | 738.32M |